Regeneron Pharmaceuticals
REGN
#233
Rank
HK$748.75 B
Marketcap
HK$7,238
Share price
-2.35%
Change (1 day)
32.28%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): HK$367.97

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$368.27. In 2025 the company made an earnings per share (EPS) of HK$338.02 an increase over its 2024 EPS that were of HK$320.46.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$367.978.86%
2025HK$338.025.48%
2024HK$320.4610.34%
2023HK$290.43-8.56%
2022HK$317.63-47%
2021HK$599.29133.36%
2020HK$256.8069.13%
2019HK$151.84-14.44%
2018HK$177.47100.71%
2017HK$88.4231.78%
2016HK$67.1038.96%
2015HK$48.2972.55%
2014HK$27.99-17.55%
2013HK$33.94-44.98%
2012HK$61.69
2010-HK$9.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.15-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$136.24-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.53-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$18.50-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.29-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA